ALKERMES | Vendas

Preço das Ações
33.16
Mudança Diária
-0.13 -0.39%
Mensal
8.30%
Anual
-7.61%
Q1 Previsão
32.16




Vendas Alterar Data
AbbVie USD 16.62B 840M 2025-12
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
ALKERMES USD 394.2M 3.5M 2025-09
Amgen USD 9.9B 340M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 7.6M 46.54M 2025-03
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Heron Therapeutics USD 32.81M 3.21M 2024-09
Ionis Pharmaceuticals USD 157M 295M 2025-09
J&J USD 24.6B 610M 2025-12
Merck USD 16.4B 880M 2025-12
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 24.12M 635K 2024-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Otsuka Holdings JPY 650.15B 12.17B 2025-12
Pfizer USD 17.58B 880M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12


ALKERMES Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.